Customized, drug-specific eFlow® Technology nebulizers are used for the treatment of lower respiratory tract diseases or for non-systemic drug delivery.
They are based on the eFlow® Technology platform whose core consists of the aerosol head with the vibrating membrane. The nebulizers are characterized by high efficiency and short nebulization times (according to the properties of the drug to be nebulized) as well as high pulmonary deposition of the generated aerosols.
eFlow® Technology nebulizers are specifically tailored to the requirements of certain drug formulations and patient groups. They are usually marketed exclusively as drug-device combination product under license by our pharmaceutical partners.
(with inspiratory/expiratory valve)
» Stores the continuously generated aerosol during exhalation
» Reduces losses during exhalation
» Produces a bolus effect – a large amount of aerosol is delivered to the patient right at the beginning of the inhalation
» Reduces inter-patient dose variability, e.g., less dependent on inter-patient differences in dead-space volume or breathing maneuvers
» Ensures high fine particle fraction
» Ensures high output rate
» Ensures proven reproducible aerosol performance
» Is easy and fast adjustable for a specific formulation
» No residual volume
» Allows a wide range of filling volumes
eFlow® Technology nebulizers can be adjusted to a variety of molecules and formulations with a broad range of fill volumes and physicochemical properties, including:
Due to available customizable platform components
Due to extensive experience in aerosols